European Journal of Vascular & Endovascular Surgery
Volume 31, Issue 2 , Pages 181-186 , February 2006

Depopulated Bovine Ureteric Xenograft for Complex Haemodialysis Vascular Access

  • C.R. Darby

      Affiliations

    • Oxford Transplant Centre, Headington, Oxford, UK
    • Department of Vascular Surgery, Headington, Oxford, UK
    • Corresponding Author InformationCorresponding author. Mr C.R. Darby, MBBS, FRCS, MD, Consultant Vascular and Transplant Surgeon, Oxford Transplant Centre, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK.
    • ,
  • D. Roy

      Affiliations

    • Oxford Transplant Centre, Headington, Oxford, UK
    • ,
  • D. Deardon

      Affiliations

    • Oxford Transplant Centre, Headington, Oxford, UK
    • ,
  • A. Cornall

      Affiliations

    • Oxford Transplant Centre, Headington, Oxford, UK

,Accepted 6 July 2005.

References 

  1. US Renal Data System (USRDS). Annual Data Report: Atlas of end Stage renal disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004;
  2. US Renal Data System (USRDS). Annual Data Report: Atlas of end stage renal disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2003;
  3. National Kidney Foundation. K/DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2001;37(Suppl 1):S137–S181
  4. Chazan JA, London MR, Pono LM. Long-term survival of vascular accesses in a large chronic hemodialysis population. Nephron. 1995;69(3):228–233
  5. Cinat ME, Hopkins J, Wilson SE. A prospective evaluation of PTFE graft patency and surveillance techniques in hemodialysis access. Ann Vasc Surg. 1999;13(2):191–198
  6. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7(4):523–535
  7. Hodges TC, Fillinger MF, Zwolak RM, Walsh DB, Bech F, Cronenwett JL. Longitudinal comparison of dialysis access methods: Risk factors for failure. J Vasc Surg. 1997;26(6):1009–1019
  8. Matsuura JH, Rosenthal D, Clark M, Shuler FW, Kirby L, Shotwell M, et al. Transposed basilic vein versus polytetrafluorethylene for brachial-axillary arteriovenous fistulas. Am J Surg. 1998;176(2):219–221
  9. Taylor SM, Eaves GL, Weatherford DA, McAlhany JC, Russell HE, Langan EM. Results and complications of arteriovenous access dialysis grafts in the lower extremity: A five year review. Am Surg. 1996;62(3):188–191
  10. Matsuura JH, Johansen KH, Rosenthal D, Clark MD, Clarke KA, Kirby LB. Cryopreserved femoral vein grafts for difficult hemodialysis access. Ann Vasc Surg. 2000;14(1):50–55
  11. Surowiec S. The use of cryopreserved femoral vein for salvage of infected arteriovenous grafts: Early results. Baltimore, MD: Association of VA surgeons; 1998;
  12. Matsuura J. Cryopreserved human femoral vein: A new option for infected access grafts. Contemporary dialysis and nephrology. p. 30–32 1999;
  13. Sabanayagam P, Schwartz AB, Soricelli RR, Lyons P, Chinitz J. A comparative study of 402 bovine heterografts and 225 reinforced expanded PTFE grafts as AVF in the ESRD patient. Trans Am Soc Artif Intern Organs. 1980;26:88–92
  14. Enzler MA, Rajmon T, Lachat M, Largiader F. Long-term function of vascular access for hemodialysis. Clin Transplant. 1996;10(6 Pt 1):511–515
  15. Brems J, Castaneda M, Garvin PJ. A five-year experience with the bovine heterograft for vascular access. Arch Surg. 1986;121(8):941–944
  16. Bacchini G. PTFE versus mesenteric bovine vein as vascular accesses in hemodialysis patients: Preliminary results of a randomized trial. London, UK: International Congress of the Vascular Access Society; 2001;
  17. Ratto GB, Romano P, Truini M, Frascio M, Rovida S, Badini A, et al. Glutaraldehyde-tanned mandril-grown grafts as venous substitutes. J Thorac Cardiovasc Surg. 1991;102(3):440–447
  18. Ratto G. Reply to the Editor regarding J Thorac Cardiovasc Surg 1991. J Thorac Cardiovasc Surg. 1994;107:949
  19. Widmer MK, Aregger F, Stauffer E, Savolainen H, Heller G, Hakki H, et al. Intermediate outcome and risk factor assessment of bovine vascular heterografts used as AV-fistulas for hemodialysis access. Eur J Vasc Endovasc Surg. 2004;27(6):660–665
  20. Clarke DR, Lust RM, Sun YS, Black KS, Ollerenshaw JD. Transformation of nonvascular acellular tissue matrices into durable vascular conduits. Ann Thorac Surg. 2001;71(5 Suppl 1):S433–S436
  21. Matsuura JH, Black KS, Levitt AB, Rosenthal D, Wellons ED, Fallon MT, et al. Cellular remodeling of depopulated bovine ureter used as an arteriovenous graft in the canine model. J Am Coll Surg. 2004;198(5):778–783
  22. Sidawy AN, Gray R, Besarab A, Henry M, Ascher E, Silva M, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg. 2002;35(3):603–610
  23. Schmitz-Rixen T, Megerman J, Anderson JM, Warnock DF, L'Italien GJ, Erasmi H, et al. Longterm study of a compliant biological vascular graft. Eur J Vasc Surg. 1991;5(2):149–158
  24. Koch G, Gutschi S, Pascher O, Fruhwirth H, Glanzer H. Analysis of 274 omniflow vascular prostheses implanted over an eight-year period. Aust N Z J Surg. 1997;67(9):637–639
  25. Raeder RH, Badylak SF, Sheehan C, Kallakury B, Metzger DW. Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts. Transpl Immunol. 2002;10(1):15–24
  26. Badylak S, Kokini K, Tullius B, Whitson B. Strength over time of a resorbable bioscaffold for body wall repair in a dog model. J Surg Res. 2001;99(2):282–287
  27. Darby C, Cornall A. Clinical outcomes of a depopulated bovine ureter (Synergraft Vascular Graft model 100) used as an arteriovenous access graft. Advances in tissue engineering and biology of heart valves, Florence, Italy, 2004.
  28. Rayner HC, Pisoni RL, Gillespie BW, Goodkin DA, Akiba T, Akizawa T, et al. Creation, cannulation and survival of arteriovenous fistulae: Data from the dialysis outcomes and practice patterns study. Kidney Int. 2003;63(1):323–330
  29. Gibson KD, Gillen DL, Caps MT, Kohler TR, Sherrard DJ, Stehman-Breen CO. Vascular access survival and incidence of revisions: A comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States renal data system dialysis morbidity and mortality study. J Vasc Surg. 2001;34(4):694–700
  30. Warakaulle D, Cornall A, Uberoi R, Darby C. Vascular bovine ureteric grafts (VBUGS) as a novel conduit in fashioning haemodialysis fistulae. Chicago, IL: RSNA; 2004;
  31. Ruddle A, Lear P, Mitchell D. The morbidity of secondary vascular access. A life time of intervention. Eur J Vasc Endovasc Surg. 1999;18(1):30–34

PII: S1078-5884(05)00463-6

doi: 10.1016/j.ejvs.2005.07.006

European Journal of Vascular & Endovascular Surgery
Volume 31, Issue 2 , Pages 181-186 , February 2006

Article Tools

* Image Usage & Resolution